FDA's ISTAND Pilot Program accepts a submission of first organ-on-a-chip technology designed to predict human drug-...
[9/24/2024] FDA's Center for Drug Evaluation and Research (CDER) has accepted the first letter of intent (LOI) into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program for an organ-on-a-chip technology, a type …